Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Eledon Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- 0 vs. Q2 2022
- Shares held
- 6.27M
- −266.8K (−4.1%) vs. Q2 2022
- Total value
- $17.3M
- +$1.35M (+8.5%) vs. Q2 2022
- New holders
- 2
- 6 more added
- Sold out
- 2
- 12 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $184.6M |
| Q1 2026 | 121 | $131.2M |
| Q4 2025 | 95 | $66.7M |
| Q3 2025 | 83 | $94.5M |
| Q2 2025 | 85 | $110.7M |
| Q1 2025 | 83 | $130.3M |
| Q4 2024 | 75 | $158.5M |
| Q3 2024 | 33 | $46.0M |
| Q2 2024 | 32 | $48.2M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 29 | $16.5M |
| Q3 2023 | 28 | $12.2M |
| Q2 2023 | 33 | $12.7M |
| Q1 2023 | 30 | $14.7M |
| Q4 2022 | 28 | $14.4M |
| Q3 2022 | 31 | $17.3M |
| Q2 2022 | 31 | $15.9M |
| Q1 2022 | 32 | $27.6M |
| Q4 2021 | 36 | $34.7M |
| Q3 2021 | 35 | $52.1M |
| Q2 2021 | 34 | $74.5M |
| Q1 2021 | 34 | $89.0M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 82 | $0 | 0.00% | −10−10.9% | Reduced |
| Cubist Systematic Strategies, LLC | 35 | $0 | 0.00% | +16+84.2% | Added |
| Royal Bank of Canada | 38 | $0 | 0.00% | +38 | New |
| Tower Research Capital LLC (TRC) | 640 | $1.00K | 0.00% | −395−38.2% | Reduced |
| Federated Hermes, Inc. | 339 | $1.00K | 0.00% | −67−16.5% | Reduced |
| Spire Wealth Management | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,014 | $3.00K | 0.00% | −3,624−78.1% | Reduced |
| Morgan Stanley | 1,133 | $3.00K | 0.00% | −899−44.2% | Reduced |
| Rockefeller Capital Management L.P. | 1,666 | $4.00K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 16,726 | $46.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 17,950 | $50.0K | 0.00% | +17,950 | New |
| Boothbay Fund Management, LLC | 22,050 | $61.0K | 0.00% | −12,580−36.3% | Reduced |
| Two Sigma Investments, LP | 29,737 | $82.0K | 0.00% | −1,400−4.5% | Reduced |
| Northern Trust Corp | 30,053 | $83.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 31,873 | $88.0K | 0.00% | −300−0.9% | Reduced |
| Two Sigma Advisers, LP | 42,200 | $116.0K | 0.00% | −2,800−6.2% | Reduced |
| State Street Corp | 44,692 | $123.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 49,365 | $136.0K | 0.00% | +1,074+2.2% | Added |
| Ingalls & Snyder LLC | 51,149 | $141.0K | 0.01% | 00.0% | Unchanged |
| Jmac Enterprises LLC | 54,538 | $151.0K | 0.04% | 00.0% | Unchanged |
| Eversept Partners, LP | 67,743 | $187.0K | 0.02% | +8,678+14.7% | Added |
| Ensign Peak Advisors, Inc | 87,286 | $241.0K | 0.00% | +10,186+13.2% | Added |
| Geode Capital Management, LLC | 129,465 | $357.0K | 0.00% | +679+0.5% | Added |
| Ikarian Capital, LLC | 221,830 | $612.0K | 0.31% | −140,707−38.8% | Reduced |
| CM Management, LLC | 245,000 | $676.0K | 0.75% | +20,000+8.9% | Added |
| Point72 Asset Management, L.P. | 375,000 | $1.03M | 0.00% | −53,360−12.5% | Reduced |
| Woodline Partners LP | 516,675 | $1.43M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 679,243 | $1.88M | 0.00% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,223,500 | $3.38M | 0.24% | −81,595−6.3% | Reduced |
| BVF Inc | 2,326,710 | $6.42M | 0.27% | 00.0% | Unchanged |
| IFP Advisors, Inc | 1 | – | – | 00.0% | Unchanged |
| Bailard, Inc. | 0 | $0 | 0.00% | −27,413−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −287−100.0% | Sold out |